This regulatory attention reflects the balance between expanding medication access through telehealth and ensuring patient safety through adequate oversight
At our Atlanta clinic, we offer two primary GLP-1 options: Semaglutide: A once-weekly injection that targets GLP-1 receptors to reduce appetite and improve blood sugar control
Long-term plans: Consider sustainability how long you and your clinician plan to continue therapy, plans for weight maintenance, and what behavioral and nutritional supports will accompany medication
Mice deficient in GPR43 exhibit an exacerbated colitis-like phenotype, while administration of SCFAs, including butyrate, ameliorates disease in wild-type but not GPR43-deficient animals, underscoring the receptors essential role in SCFA-mediated intestinal protection (Masui et al., 2013
"ING Direct rebranded as Capital One 360"
However, emerging human data have not shown an increased risk of major birth defects when GLP-1s were used during early pregnancy
